Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(11):788-789; doi:10.1093/jnci/dji167
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wefel, J. S.
Right arrow Articles by Meyers, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wefel, J. S.
Right arrow Articles by Meyers, C. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

EDITORIAL

Cancer as a Risk Factor for Dementia: A House Built on Shifting Sand

Jeffrey S. Wefel, Christina A. Meyers

Affiliation of authors: Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston

Correspondence to: Jeffrey S. Wefel, PhD, Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 431, Houston, TX 77030 (e-mail: jwefel@mdanderson.org).

The first 10% of the full text of this article appears below.

As advances in therapy have improved the survival rates of patients diagnosed with cancer, various survivorship issues have received attention, including the incidence of cognitive dysfunction and its relative impact on patient quality of life. For example, patients with breast and prostate cancer have 5-year relative survival rates of approximately 86% and 98%, respectively (1). However, recent studies have demonstrated that cognitive dysfunction may be present before treatment, may worsen acutely secondary to treatment-related neurotoxicity, and may continue after cessation of therapy (2–5). Concerns that exposure to cancer and cancer treatments may augment a patient's chance of developing future neurologic diseases, including dementia, have also received recent attention. These concerns are amplified in an aging population that has an increased risk for both cancer and . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The OncologistHome page
J. Dietrich, M. Monje, J. Wefel, and C. Meyers
Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy
Oncologist, December 1, 2008; 13(12): 1285 - 1295.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. S. Wefel and C. A. Meyers
RESPONSE: Re: Cancer as a Risk Factor for Dementia: A House Built on Shifting Sand
J Natl Cancer Inst, October 19, 2005; 97(20): 1551 - 1552.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. H. Heflin, B. E. Meyerowitz, P. Hall, P. Lichtenstein, B. Johansson, N. L. Pedersen, and M. Gatz
Re: Cancer as a Risk Factor for Dementia: A House Built on Shifting Sand
J Natl Cancer Inst, October 19, 2005; 97(20): 1550 - 1551.
[Full Text] [PDF]